{"id":1812,"date":"2023-01-05T15:18:51","date_gmt":"2023-01-05T15:18:51","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1812"},"modified":"2026-02-23T00:23:03","modified_gmt":"2026-02-23T00:23:03","slug":"differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2023\/01\/05\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\/","title":{"rendered":"Differential rates of germline heterozygote and mosaic variants in NF2 may show varying propensity for meiotic or mitotic mutation (Contributed by Prof. Evans Gareth)"},"content":{"rendered":"

NF2-related-schwannomatosis is characterised by the development of benign tumours of nerve sheaths (schwannomas) and lining of the brain (meningiomas). Around 50\u201460% of affected people are the first in their family and half of these have genetic faults that change an amino acid to an instruction to stop making protein (nonsense). Although there are 60 positions in the NF2 code where nonsense variants have occurred, only six, all at \u2018C\u2019 letters that change CGA to TGA, account for half of all nonsense variations. These are far more common in NF2 than in APC which causes a similar tumour condition. (https:\/\/jmg.bmj.com\/content\/early\/2023\/01\/03\/jmg-2022-108960<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

NF2-related-schwannomatosis is characterised by the development of benign tumours of nerve sheaths (schwannomas) and lining of the brain (meningiomas). Around 50\u201460% of affected people are the first in their family and half of these have genetic faults that change an amino acid to an instruction to stop making protein (nonsense). Although there are 60 positions […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1812","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nDifferential rates of germline heterozygote and mosaic variants in NF2 may show varying propensity for meiotic or mitotic mutation (Contributed by Prof. Evans Gareth) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2023\/01\/05\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Differential rates of germline heterozygote and mosaic variants in NF2 may show varying propensity for meiotic or mitotic mutation (Contributed by Prof. Evans Gareth) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"NF2-related-schwannomatosis is characterised by the development of benign tumours of nerve sheaths (schwannomas) and lining of the brain (meningiomas). Around 50\u201460% of affected people are the first in their family and half of these have genetic faults that change an amino acid to an instruction to stop making protein (nonsense). Although there are 60 positions [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2023\/01\/05\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-05T15:18:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-23T00:23:03+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/01\\\/05\\\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/01\\\/05\\\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Differential rates of germline heterozygote and mosaic variants in NF2 may show varying propensity for meiotic or mitotic mutation (Contributed by Prof. Evans Gareth)\",\"datePublished\":\"2023-01-05T15:18:51+00:00\",\"dateModified\":\"2026-02-23T00:23:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/01\\\/05\\\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\\\/\"},\"wordCount\":129,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/01\\\/05\\\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/01\\\/05\\\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/01\\\/05\\\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\\\/\",\"name\":\"Differential rates of germline heterozygote and mosaic variants in NF2 may show varying propensity for meiotic or mitotic mutation (Contributed by Prof. Evans Gareth) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2023-01-05T15:18:51+00:00\",\"dateModified\":\"2026-02-23T00:23:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/01\\\/05\\\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/01\\\/05\\\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/01\\\/05\\\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Differential rates of germline heterozygote and mosaic variants in NF2 may show varying propensity for meiotic or mitotic mutation (Contributed by Prof. Evans Gareth)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Differential rates of germline heterozygote and mosaic variants in NF2 may show varying propensity for meiotic or mitotic mutation (Contributed by Prof. Evans Gareth) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2023\/01\/05\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\/","og_locale":"en_US","og_type":"article","og_title":"Differential rates of germline heterozygote and mosaic variants in NF2 may show varying propensity for meiotic or mitotic mutation (Contributed by Prof. Evans Gareth) - JMG Contact blog","og_description":"NF2-related-schwannomatosis is characterised by the development of benign tumours of nerve sheaths (schwannomas) and lining of the brain (meningiomas). Around 50\u201460% of affected people are the first in their family and half of these have genetic faults that change an amino acid to an instruction to stop making protein (nonsense). Although there are 60 positions [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2023\/01\/05\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\/","og_site_name":"JMG Contact blog","article_published_time":"2023-01-05T15:18:51+00:00","article_modified_time":"2026-02-23T00:23:03+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/01\/05\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/01\/05\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Differential rates of germline heterozygote and mosaic variants in NF2 may show varying propensity for meiotic or mitotic mutation (Contributed by Prof. Evans Gareth)","datePublished":"2023-01-05T15:18:51+00:00","dateModified":"2026-02-23T00:23:03+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/01\/05\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\/"},"wordCount":129,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2023\/01\/05\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/01\/05\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\/","url":"https:\/\/blogs.bmj.com\/jmg\/2023\/01\/05\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\/","name":"Differential rates of germline heterozygote and mosaic variants in NF2 may show varying propensity for meiotic or mitotic mutation (Contributed by Prof. Evans Gareth) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2023-01-05T15:18:51+00:00","dateModified":"2026-02-23T00:23:03+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/01\/05\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2023\/01\/05\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/01\/05\/differential-rates-of-germline-heterozygote-and-mosaic-variants-in-nf2-may-show-varying-propensity-for-meiotic-or-mitotic-mutation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Differential rates of germline heterozygote and mosaic variants in NF2 may show varying propensity for meiotic or mitotic mutation (Contributed by Prof. Evans Gareth)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1812"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1812\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}